Exploiting immunostimulatory mechanisms of immunogenic cell death to develop membrane-encapsulated nanoparticles as a potent tumor vaccine.
J Nanobiotechnology
; 21(1): 326, 2023 Sep 08.
Article
in En
| MEDLINE
| ID: mdl-37684628
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Cancer Vaccines
Type of study:
Prognostic_studies
Language:
En
Journal:
J Nanobiotechnology
Year:
2023
Type:
Article
Affiliation country:
China